UHRF1 downmodulation enhances antitumor effects of histone deacetylase inhibitors in retinoblastoma by augmenting oxidative stress‐mediated apoptosis

Identification of new genetic pathways or molecular targets that sensitize cancer cells to chemotherapeutic drugs may improve the efficacy of current chemotherapy. Here, we report that downmodulation of UHRF1 (ubiquitin‐like with PHD and RING finger domains 1) in retinoblastoma (RB) cells increases...

Full description

Bibliographic Details
Main Authors: Jong Kyong Kim, Guangyan Kan, Yu Mao, Zhixuan Wu, Xionghong Tan, Heng He, Chunsik Lee
Format: Article
Language:English
Published: Wiley 2020-02-01
Series:Molecular Oncology
Subjects:
Online Access:https://doi.org/10.1002/1878-0261.12607
_version_ 1797819826982354944
author Jong Kyong Kim
Guangyan Kan
Yu Mao
Zhixuan Wu
Xionghong Tan
Heng He
Chunsik Lee
author_facet Jong Kyong Kim
Guangyan Kan
Yu Mao
Zhixuan Wu
Xionghong Tan
Heng He
Chunsik Lee
author_sort Jong Kyong Kim
collection DOAJ
description Identification of new genetic pathways or molecular targets that sensitize cancer cells to chemotherapeutic drugs may improve the efficacy of current chemotherapy. Here, we report that downmodulation of UHRF1 (ubiquitin‐like with PHD and RING finger domains 1) in retinoblastoma (RB) cells increases the sensitivity to histone deacetylase (HDAC) inhibitors, augmenting apoptotic cell death. We found that UHRF1 depletion downregulates two redox‐responsive genes GSTA4 (glutathione S‐transferase α4) and TXN2 (thioredoxin‐2) in RB cells, and increases the basal level of intracellular oxidative stress. Antioxidant treatment significantly reduced both basal and HDAC inhibitor‐induced DNA damage and apoptosis in UHRF1‐depleted cells. Knockdown of GSTA4 or TXN2 sensitized RB cells to HDAC inhibitors, demonstrating that GSTA4 and TXN2 play key roles in redox homeostasis in RB cells and the susceptibility to HDAC inhibitor treatment upon UHRF1 depletion. In human primary RB, GSTA4 and TXN2 proteins were found to be mostly elevated along with high UHRF1 expression. In addition to augmentation of apoptosis in UHRF1‐depleted RB cells, we also show that UHRF1 downmodulation derepresses the expression of photoreceptor‐specific genes in RB cells in cooperation with a HDAC inhibitor MS‐275 and promotes neuron‐like differentiation. However, further investigation revealed that the enhanced growth‐inhibitory effects of MS‐275 in UHRF1‐depleted cells were still mainly due to robust apoptosis induction rather than differentiation‐mediated growth arrest. Consistent with our findings, UHRF1 depletion in RB cells increased the therapeutic efficacy of MS‐275 in murine orthotopic xenografts. These results provide a novel basis for potential benefits of UHRF1 targeting for RB treatment.
first_indexed 2024-03-13T09:28:22Z
format Article
id doaj.art-8c0b5e5dbf4446f8b51da51d77bcd496
institution Directory Open Access Journal
issn 1574-7891
1878-0261
language English
last_indexed 2024-03-13T09:28:22Z
publishDate 2020-02-01
publisher Wiley
record_format Article
series Molecular Oncology
spelling doaj.art-8c0b5e5dbf4446f8b51da51d77bcd4962023-05-26T04:31:40ZengWileyMolecular Oncology1574-78911878-02612020-02-0114232934610.1002/1878-0261.12607UHRF1 downmodulation enhances antitumor effects of histone deacetylase inhibitors in retinoblastoma by augmenting oxidative stress‐mediated apoptosisJong Kyong Kim0Guangyan Kan1Yu Mao2Zhixuan Wu3Xionghong Tan4Heng He5Chunsik Lee6State Key Laboratory of Ophthalmology Zhongshan Ophthalmic Center Sun Yat‐sen University Guangzhou ChinaState Key Laboratory of Ophthalmology Zhongshan Ophthalmic Center Sun Yat‐sen University Guangzhou ChinaState Key Laboratory of Ophthalmology Zhongshan Ophthalmic Center Sun Yat‐sen University Guangzhou ChinaState Key Laboratory of Ophthalmology Zhongshan Ophthalmic Center Sun Yat‐sen University Guangzhou ChinaState Key Laboratory of Ophthalmology Zhongshan Ophthalmic Center Sun Yat‐sen University Guangzhou ChinaState Key Laboratory of Ophthalmology Zhongshan Ophthalmic Center Sun Yat‐sen University Guangzhou ChinaState Key Laboratory of Ophthalmology Zhongshan Ophthalmic Center Sun Yat‐sen University Guangzhou ChinaIdentification of new genetic pathways or molecular targets that sensitize cancer cells to chemotherapeutic drugs may improve the efficacy of current chemotherapy. Here, we report that downmodulation of UHRF1 (ubiquitin‐like with PHD and RING finger domains 1) in retinoblastoma (RB) cells increases the sensitivity to histone deacetylase (HDAC) inhibitors, augmenting apoptotic cell death. We found that UHRF1 depletion downregulates two redox‐responsive genes GSTA4 (glutathione S‐transferase α4) and TXN2 (thioredoxin‐2) in RB cells, and increases the basal level of intracellular oxidative stress. Antioxidant treatment significantly reduced both basal and HDAC inhibitor‐induced DNA damage and apoptosis in UHRF1‐depleted cells. Knockdown of GSTA4 or TXN2 sensitized RB cells to HDAC inhibitors, demonstrating that GSTA4 and TXN2 play key roles in redox homeostasis in RB cells and the susceptibility to HDAC inhibitor treatment upon UHRF1 depletion. In human primary RB, GSTA4 and TXN2 proteins were found to be mostly elevated along with high UHRF1 expression. In addition to augmentation of apoptosis in UHRF1‐depleted RB cells, we also show that UHRF1 downmodulation derepresses the expression of photoreceptor‐specific genes in RB cells in cooperation with a HDAC inhibitor MS‐275 and promotes neuron‐like differentiation. However, further investigation revealed that the enhanced growth‐inhibitory effects of MS‐275 in UHRF1‐depleted cells were still mainly due to robust apoptosis induction rather than differentiation‐mediated growth arrest. Consistent with our findings, UHRF1 depletion in RB cells increased the therapeutic efficacy of MS‐275 in murine orthotopic xenografts. These results provide a novel basis for potential benefits of UHRF1 targeting for RB treatment.https://doi.org/10.1002/1878-0261.12607chemotherapydrug sensitivityHDAC inhibitorsretinoblastomaUHRF1
spellingShingle Jong Kyong Kim
Guangyan Kan
Yu Mao
Zhixuan Wu
Xionghong Tan
Heng He
Chunsik Lee
UHRF1 downmodulation enhances antitumor effects of histone deacetylase inhibitors in retinoblastoma by augmenting oxidative stress‐mediated apoptosis
Molecular Oncology
chemotherapy
drug sensitivity
HDAC inhibitors
retinoblastoma
UHRF1
title UHRF1 downmodulation enhances antitumor effects of histone deacetylase inhibitors in retinoblastoma by augmenting oxidative stress‐mediated apoptosis
title_full UHRF1 downmodulation enhances antitumor effects of histone deacetylase inhibitors in retinoblastoma by augmenting oxidative stress‐mediated apoptosis
title_fullStr UHRF1 downmodulation enhances antitumor effects of histone deacetylase inhibitors in retinoblastoma by augmenting oxidative stress‐mediated apoptosis
title_full_unstemmed UHRF1 downmodulation enhances antitumor effects of histone deacetylase inhibitors in retinoblastoma by augmenting oxidative stress‐mediated apoptosis
title_short UHRF1 downmodulation enhances antitumor effects of histone deacetylase inhibitors in retinoblastoma by augmenting oxidative stress‐mediated apoptosis
title_sort uhrf1 downmodulation enhances antitumor effects of histone deacetylase inhibitors in retinoblastoma by augmenting oxidative stress mediated apoptosis
topic chemotherapy
drug sensitivity
HDAC inhibitors
retinoblastoma
UHRF1
url https://doi.org/10.1002/1878-0261.12607
work_keys_str_mv AT jongkyongkim uhrf1downmodulationenhancesantitumoreffectsofhistonedeacetylaseinhibitorsinretinoblastomabyaugmentingoxidativestressmediatedapoptosis
AT guangyankan uhrf1downmodulationenhancesantitumoreffectsofhistonedeacetylaseinhibitorsinretinoblastomabyaugmentingoxidativestressmediatedapoptosis
AT yumao uhrf1downmodulationenhancesantitumoreffectsofhistonedeacetylaseinhibitorsinretinoblastomabyaugmentingoxidativestressmediatedapoptosis
AT zhixuanwu uhrf1downmodulationenhancesantitumoreffectsofhistonedeacetylaseinhibitorsinretinoblastomabyaugmentingoxidativestressmediatedapoptosis
AT xionghongtan uhrf1downmodulationenhancesantitumoreffectsofhistonedeacetylaseinhibitorsinretinoblastomabyaugmentingoxidativestressmediatedapoptosis
AT henghe uhrf1downmodulationenhancesantitumoreffectsofhistonedeacetylaseinhibitorsinretinoblastomabyaugmentingoxidativestressmediatedapoptosis
AT chunsiklee uhrf1downmodulationenhancesantitumoreffectsofhistonedeacetylaseinhibitorsinretinoblastomabyaugmentingoxidativestressmediatedapoptosis